These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38149454)
1. TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5'UTR, and IL-15 against experimental glioblastoma. Wang J; Zhang J; Zhang Q; Zhang W; Zhang Q; Jin G; Liu F J Med Virol; 2024 Jan; 96(1):e29335. PubMed ID: 38149454 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma. Wang P; Zhang J; Zhang Q; Liu F Biomed Pharmacother; 2023 Jan; 157():114035. PubMed ID: 36434955 [TBL] [Abstract][Full Text] [Related]
3. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Wohlfahrt ME; Beard BC; Lieber A; Kiem HP Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719 [TBL] [Abstract][Full Text] [Related]
4. Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment. Zhang Q; Zhang J; Wang P; Zhu G; Jin G; Liu F Stem Cell Res Ther; 2022 Jun; 13(1):284. PubMed ID: 35765095 [TBL] [Abstract][Full Text] [Related]
5. Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation. Kim SY; Kang D; Choi HJ; Joo Y; Kim JH; Song JJ Oncotarget; 2017 Feb; 8(9):15858-15877. PubMed ID: 28178658 [TBL] [Abstract][Full Text] [Related]
6. Ki67-targeted oncolytic adenovirus expressing IL-15 improves intratumoral T cell infiltration and PD-L1 expression in glioblastoma. Zhang Q; Zhang J; Tian Y; Wang J; Jin G; Liu F Virology; 2023 Oct; 587():109885. PubMed ID: 37738842 [TBL] [Abstract][Full Text] [Related]
7. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy. Ulasov IV; Shah N; Kaverina NV; Lee H; Lin B; Lieber A; Kadagidze ZG; Yoon JG; Schroeder B; Hothi P; Ghosh D; Baryshnikov AY; Cobbs CS Oncotarget; 2015 Feb; 6(6):3977-87. PubMed ID: 25738357 [TBL] [Abstract][Full Text] [Related]
8. A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma. Oh E; Hong J; Kwon OJ; Yun CO Sci Rep; 2018 Jan; 8(1):1420. PubMed ID: 29362367 [TBL] [Abstract][Full Text] [Related]
9. Cell Membrane-Coated Oncolytic Adenovirus for Targeted Treatment of Glioblastoma. Jia X; Wang L; Feng X; Liu W; Wang X; Li F; Liu X; Yu J; Yu B; Yu X Nano Lett; 2023 Dec; 23(23):11120-11128. PubMed ID: 38032110 [TBL] [Abstract][Full Text] [Related]
10. TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion. Zhang C; Zhang X; Xu R; Huang B; Chen AJ; Li C; Wang J; Li XG J Exp Clin Cancer Res; 2017 Nov; 36(1):162. PubMed ID: 29145888 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells. Zhang Q; Zhang J; Tian Y; Zhu G; Liu S; Liu F Cell Biosci; 2020; 10():124. PubMed ID: 33133514 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells. Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503 [TBL] [Abstract][Full Text] [Related]
14. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell. Liu J; Fang L; Cheng Q; Li L; Su C; Zhang B; Pei D; Yang J; Li W; Zheng J Cancer Sci; 2012 Oct; 103(10):1880-8. PubMed ID: 22775978 [TBL] [Abstract][Full Text] [Related]
15. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model. Wang H; Wei F; Li H; Ji X; Li S; Chen X Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955 [TBL] [Abstract][Full Text] [Related]
16. CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma. Wang G; Zhang Z; Zhong K; Wang Z; Yang N; Tang X; Li H; Lu Q; Wu Z; Yuan B; Zheng M; Cheng P; Tong A; Zhou L Mol Ther; 2023 Jan; 31(1):134-153. PubMed ID: 36056553 [TBL] [Abstract][Full Text] [Related]
17. Increased transforming growth factor-β2 in epidermal growth factor receptor variant III-positive glioblastoma. Zhang X; Wu A; Fan Y; Wang Y J Clin Neurosci; 2011 Jun; 18(6):821-6. PubMed ID: 21511480 [TBL] [Abstract][Full Text] [Related]
19. Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy. Martinez-Quintanilla J; He D; Wakimoto H; Alemany R; Shah K Mol Ther; 2015 Jan; 23(1):108-18. PubMed ID: 25352242 [TBL] [Abstract][Full Text] [Related]
20. The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model. Klawitter M; El-Ayoubi A; Buch J; Rüttinger J; Ehrenfeld M; Lichtenegger E; Krüger MA; Mantwill K; Koll FJ; Kowarik MC; Holm PS; Naumann U Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]